No results for ‘’
Modipon Ltd
NSE: MODIPON BSE: 503776
₹34
(0%)
Tue, 28 Jul 2026, 01:52 am
Market Cap (in Cr)39.36
PE Ratio0
Dividend0
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Modipon Analysis
dividend
Pros
Cons
- Unable to evaluate Modipon's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Modipon's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
- Low level of unsold assets.
Cons
- Modipon's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not well covered by operating cash flow (2.7%, less than 20% of total debt).
- Modipon has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
- Modipon's long term commitments exceed its cash and other short term assets.
- Irrelevant to check if Modipon's debt level has increased considering it has negative shareholder equity.
- Modipon has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
management
Pros
- The tenure for the Modipon board of directors is about average.
- Manish's remuneration is lower than average for companies of similar size in India.
- Manish's compensation has been consistent with company performance over the past year, both up more than 20%.
Cons
misc
Pros
Cons
- Modipon is not covered by any analysts.
- Modipon has significant price volatility in the past 3 months.
past
Pros
Cons
- Unable to compare Modipon's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Modipon does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Modipon has efficiently used its assets last year compared to the IN Chemicals industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Modipon improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
- It is difficult to establish if Modipon has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
- Unable to compare Modipon's 1-year growth to the IN Chemicals industry average as it is not currently profitable.
value
Pros
- BSE:503776 is up 32.8% outperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:503776 is up 32.8% outperforming the market in India which returned 8% over the past month.
Cons
- Modipon's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Modipon's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Modipon has negative assets, we can't compare the value of its assets to the IN Chemicals industry average.
- Modipon is loss making, we can't compare its value to the IN Chemicals industry average.
- Modipon is loss making, we can't compare the value of its earnings to the India market.
- 503776 underperformed the Chemicals industry which returned 2.2% over the past year.
- 503776 underperformed the Market in India which returned -14.5% over the past year.